{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:34:28Z","timestamp":1794375268580,"version":"4.9.0"},"publisher-location":"Boston, MA","reference-count":56,"publisher":"Springer US","isbn-type":[{"value":"9781441902832","type":"print"},{"value":"9781441902849","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009]]},"DOI":"10.1007\/978-1-4419-0284-9_28","type":"book-chapter","created":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T10:41:26Z","timestamp":1267526486000},"page":"479-496","source":"Crossref","is-referenced-by-count":89,"title":["How the NOTCH Pathway Contributes to the Ability of Osteosarcoma Cells to Metastasize"],"prefix":"10.1007","author":[{"given":"Dennis P. M.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,12]]},"reference":[{"issue":"5415","key":"28_CR1_28","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.284.5415.770","volume":"284","author":"S Artavanis-Tsakonas","year":"1999","unstructured":"Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284(5415):770-776.","journal-title":"Science"},{"issue":"12","key":"28_CR2_28","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1101\/gad.12.12.1751","volume":"12","author":"I Greenwald","year":"1998","unstructured":"Greenwald I. LIN-12\/Notch signaling: lessons from worms and flies. Genes & Dev. 1998;12(12):1751-1762.","journal-title":"Genes & Dev"},{"issue":"Suppl_1","key":"28_CR3_28","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1093\/hmg\/ddg052","volume":"12","author":"T Gridley","year":"2003","unstructured":"Gridley T. Notch signaling and inherited disease syndromes. Hum Mol Genet. 2003;12(Suppl_1):R9-R13. %R 10.1093\/hmg\/ddg052.","journal-title":"Hum Mol Genet"},{"issue":"21","key":"28_CR4_28","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1093\/hmg\/11.21.2615","volume":"11","author":"D Hartmann","year":"2002","unstructured":"Hartmann D, et al. The disintegrin\/metalloprotease ADAM 10 is essential for Notch signalling but not for {alpha}-secretase activity in fibroblasts. Hum Mol Genet. 2002;11(21):2615-2624. %R 10.1093\/hmg\/11.21.2615.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"28_CR5_28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrm910","volume":"3","author":"M Fortini","year":"2002","unstructured":"Fortini M. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev Mol Cell Biol. 2002;3(9):673-684.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"28_CR6_28","first-page":"229","volume":"9","author":"M Schnabel","year":"2002","unstructured":"Schnabel M, et al. Differential expression of Notch genes in human osteoblastic cells. Int J Mol Med. 2002;9(3):229-232.","journal-title":"Int J Mol Med"},{"issue":"12","key":"28_CR7_28","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1210\/en.2003-0463","volume":"144","author":"M Sciaudone","year":"2003","unstructured":"Sciaudone M, et al. Notch 1 impairs osteoblastic cell differentiation. Endocrinology. 2003;144(12):5631-5639.","journal-title":"Endocrinology"},{"issue":"2","key":"28_CR8_28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1359\/jbmr.2002.17.2.231","volume":"17","author":"K Tezuka","year":"2002","unstructured":"Tezuka K, et al. Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res. 2002;17(2):231-239.","journal-title":"J Bone Miner Res"},{"issue":"6","key":"28_CR9_28","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1182\/blood-2002-06-1740","volume":"101","author":"T Yamada","year":"2003","unstructured":"Yamada T, et al. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Blood. 2003;101(6):2227-2234.","journal-title":"Blood"},{"key":"28_CR10_28","doi-asserted-by":"publisher","unstructured":"Bai S, et al. Notch1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J Biol Chem. 2007;M707000200 ( %R 10.1074\/jbc.M707000200 ).","DOI":"10.1007\/978-1-4419-0284-9_28"},{"issue":"1","key":"28_CR11_28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S8756-3282(99)00099-X","volume":"25","author":"DJ Dallas","year":"1999","unstructured":"Dallas DJ, et al. Localization of ADAM10 and Notch receptors in bone. Bone. 1999;25(1):9-15.","journal-title":"Bone"},{"issue":"5","key":"28_CR12_28","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1242\/dev.126.5.987","volume":"126","author":"R Crowe","year":"1999","unstructured":"Crowe R, Zikherman J, Niswander L. Delta-1 negatively regulates the transition from prehypertrophic to hypertrophic chondrocytes during cartilage formation. Development. 1999;126(5):987-998.","journal-title":"Development"},{"issue":"4","key":"28_CR13_28","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/dvdy.20590","volume":"234","author":"JC Francis","year":"2005","unstructured":"Francis JC, Radtke F, Logan MP. Notch1 signals through Jagged2 to regulate apoptosis in the apical ectodermal ridge of the developing limb bud. Dev Dyn. 2005;234(4):1006-1015.","journal-title":"Dev Dyn"},{"issue":"6","key":"28_CR14_28","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0955-0674(97)80090-7","volume":"9","author":"KD Irvine","year":"1997","unstructured":"Irvine KD, Vogt TF. Dorsal-ventral signaling in limb development. Curr Opin Cell Biol. 1997;9(6):867-876.","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"28_CR15_28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1073\/pnas.0608281104","volume":"104","author":"K Schuster-Gossler","year":"2007","unstructured":"Schuster-Gossler K, Cordes R, Gossler A. Premature myogenic differentiation and depletion of progenitor cells cause severe muscle hypotrophy in Delta1 mutants. Proc Natl Acad Sci USA. 2007;104(2):537-542. %R 10.1073\/pnas.0608281104.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"28_CR16_28","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1242\/dev.129.7.1795","volume":"129","author":"SL Dunwoodie","year":"2002","unstructured":"Dunwoodie SL, et al. Axial skeletal defects caused by mutation in the spondylocostal dysplasia\/pudgy gene Dll3 are associated with disruption of the segmentation clock within the presomitic mesoderm. Development. 2002;129(7):1795-1806.","journal-title":"Development"},{"issue":"3","key":"28_CR17_28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/961","volume":"19","author":"K Kusumi","year":"1998","unstructured":"Kusumi K, et al. The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundaries. Nat Genet. 1998;19(3):274-278.","journal-title":"Nat Genet"},{"issue":"2","key":"28_CR18_28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/gene.20034","volume":"39","author":"K Kusumi","year":"2004","unstructured":"Kusumi K, et al. Dll3 pudgy mutation differentially disrupts dynamic expression of somite genes. Genesis. 2004;39(2):115-121.","journal-title":"Genesis"},{"issue":"6652","key":"28_CR19_28","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/39587","volume":"389","author":"A Sidow","year":"1997","unstructured":"Sidow A, et al. Serrate2 is disrupted in the mouse limb-development mutant syndactylism. Nature. 1997;389(6652):722-725.","journal-title":"Nature"},{"issue":"4","key":"28_CR20_28","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/74307","volume":"24","author":"MP Bulman","year":"2000","unstructured":"Bulman MP, et al. Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat Genet. 2000;24(4):438-441.","journal-title":"Nat Genet"},{"issue":"22","key":"28_CR21_28","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/hmg\/ddm222","volume":"16","author":"JB-D Ponio","year":"2007","unstructured":"Ponio JB-D, et al. Biological function of mutant forms of JAGGED1 proteins in Alagille syndrome: inhibitory effect on Notch signaling. Hum Mol Genet. 2007;16(22):2683-2692. %R 10.1093\/hmg\/ddm222.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"28_CR22_28","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/hmg\/7.9.1363","volume":"7","author":"ZR Yuan","year":"1998","unstructured":"Yuan ZR, et al. Mutational analysis of the Jagged 1 gene in Alagille syndrome families. Hum Mol Genet. 1998;7(9):1363-1369. %R 10.1093\/hmg\/7.9.1363.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"28_CR23_28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/ng0797-243","volume":"16","author":"L Li","year":"1997","unstructured":"Li L, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet. 1997;16(3):243-251.","journal-title":"Nat Genet"},{"issue":"6","key":"28_CR24_28","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/dvdy.21182","volume":"236","author":"PD Turnpenny","year":"2007","unstructured":"Turnpenny PD, et al. Abnormal vertebral segmentation and the Notch signaling pathway in man. Dev Dyn. 2007;236(6):1456-1474.","journal-title":"Dev Dyn"},{"issue":"5","key":"28_CR25_28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4161\/cbt.1.5.159","volume":"1","author":"E Allenspach","year":"2002","unstructured":"Allenspach E, et al. Notch signaling in cancer. Cancer Biol Ther. 2002;1(5):466-476.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"28_CR26_28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","volume":"66","author":"L Ellisen","year":"1991","unstructured":"Ellisen L, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66(4):649-661.","journal-title":"Cell"},{"issue":"5","key":"28_CR27_28","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","volume":"183","author":"W Pear","year":"1996","unstructured":"Pear W, et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med. 1996;183(5):2283-2291.","journal-title":"J Exp Med"},{"issue":"3","key":"28_CR28_28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1101\/gad.960702","volume":"16","author":"B Reizis","year":"2002","unstructured":"Reizis B, Leder P. Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. Genes & Dev. 2002;16(3):295-300.","journal-title":"Genes & Dev"},{"issue":"12","key":"28_CR29_28","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1182\/blood-2005-01-0355","volume":"106","author":"PA Zweidler-McKay","year":"2005","unstructured":"Zweidler-McKay PA, et al. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood. 2005;106(12):3898-3906.","journal-title":"Blood"},{"key":"28_CR30_28","doi-asserted-by":"crossref","unstructured":"Sutphin RM, et al. Notch agonists: emerging as a feasible therapeutic approach in AML. Blood (ASH Annual Meeting Abstracts) 2006; 108(11): 1419.","DOI":"10.1182\/blood.V108.11.1419.1419"},{"issue":"5","key":"28_CR31_28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.semcancer.2004.04.015","volume":"14","author":"B Collins","year":"2004","unstructured":"Collins B, Kleeberger W, Ball D. Notch in lung development and lung cancer. Semin Cancer Biol. 2004;14(5):357-364.","journal-title":"Semin Cancer Biol"},{"issue":"42","key":"28_CR32_28","doi-asserted-by":"publisher","first-page":"6598","DOI":"10.1038\/sj.onc.1206758","volume":"22","author":"B Nickoloff","year":"2003","unstructured":"Nickoloff B, Osborne B, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene. 2003;22(42):6598-6608.","journal-title":"Oncogene"},{"issue":"10","key":"28_CR33_28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nrc1186","volume":"3","author":"F Radtke","year":"2003","unstructured":"Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer. 2003;3(10):756-767.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"28_CR34_28","first-page":"7291","volume":"61","author":"J Shou","year":"2001","unstructured":"Shou J, et al. Dynamics of Notch expression during murine prostate development and tumorigenesis. Cancer Res. 2001;61(19):7291-7297.","journal-title":"Cancer Res"},{"issue":"4","key":"28_CR35_28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/jcb.21509","volume":"102","author":"JM Bailey","year":"2007","unstructured":"Bailey JM, Singh PK, Hollingsworth MA. Cancer metastasis facilitated by developmental pathways: sonic hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem. 2007;102(4):829-839.","journal-title":"J Cell Biochem"},{"issue":"5","key":"28_CR36_28","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1158\/0008-5472.CAN-06-3958","volume":"67","author":"I-M Shih","year":"2007","unstructured":"Shih I-M, Wang T-L. Notch signaling, {gamma}-secretase inhibitors, and cancer therapy. Cancer Res. 2007;67(5):1879-1882. %R 10.1158\/0008-5472.CAN-06-3958.","journal-title":"Cancer Res"},{"issue":"18","key":"28_CR37_28","doi-asserted-by":"publisher","first-page":"8931","DOI":"10.1158\/0008-5472.CAN-06-1858","volume":"66","author":"M Dominguez","year":"2006","unstructured":"Dominguez M. Interplay between Notch signaling and epigenetic silencers in cancer. Cancer Res. 2006;66(18):8931-8934. %R 10.1158\/0008-5472.CAN-06-1858.","journal-title":"Cancer Res"},{"issue":"15","key":"28_CR38_28","doi-asserted-by":"publisher","first-page":"7438","DOI":"10.1158\/0008-5472.CAN-06-0793","volume":"66","author":"A Proweller","year":"2006","unstructured":"Proweller A, et al. Impaired Notch signaling promotes de novo squamous cell carcinoma formation. Cancer Res. 2006;66(15):7438-7444. %R 10.1158\/0008-5472.CAN-06-0793.","journal-title":"Cancer Res"},{"issue":"5","key":"28_CR39_28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1634\/theoncologist.12-5-535","volume":"12","author":"M Kunnimalaiyaan","year":"2007","unstructured":"Kunnimalaiyaan M, Chen H. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. Oncologist. 2007;12(5):535-542. %R 10.1634\/theoncologist.12-5-535.","journal-title":"Oncologist"},{"issue":"10","key":"28_CR40_28","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1158\/1078-0432.CCR-07-1992","volume":"14","author":"P Zhang","year":"2008","unstructured":"Zhang P, et al. Critical role of Notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res. 2008;14(10):2962-2969. %R 10.1158\/1078-0432.CCR-07-1992.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"28_CR41_28","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1158\/0008-5472.CAN-03-3096","volume":"64","author":"DPM Hughes","year":"2004","unstructured":"Hughes DPM, et al. Cell surface expression of epidermal growth factor receptor and her-2 with nuclear expression of her-4 in primary osteosarcoma. Cancer Res. 2004;64(6):2047-2053.","journal-title":"Cancer Res"},{"issue":"5","key":"28_CR42_28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/pbc.20454","volume":"46","author":"DPM Hughes","year":"2006","unstructured":"Hughes DPM, et al. Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 Inhibition. Pediatr Blood Cancer. 2006;46(5):614-623.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"28_CR43_28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/sj.cgt.7700432","volume":"9","author":"S Jia","year":"2002","unstructured":"Jia S, et al. Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector. Cancer Gene Ther. 2002;9(3):260-266.","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"28_CR44_28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00001813-200202000-00007","volume":"13","author":"S Jia","year":"2002","unstructured":"Jia S, et al. Eradication of osteosarcoma lung metastasis using intranasal gemcitabine. Anticancer Drugs. 2002;13(2):155-161.","journal-title":"Anticancer Drugs"},{"issue":"1","key":"28_CR45_28","first-page":"35","volume":"6","author":"S Pollack","year":"2005","unstructured":"Pollack S, Lewis H. Secretase inhibitors for Alzheimer\u2019s disease: challenges of a promiscuous protease. Curr Opin Investig Drugs. 2005;6(1):35-47.","journal-title":"Curr Opin Investig Drugs"},{"issue":"20","key":"28_CR46_28","doi-asserted-by":"publisher","first-page":"19777","DOI":"10.1074\/jbc.M412457200","volume":"280","author":"GA Vidal","year":"2005","unstructured":"Vidal GA, et al. Presenilin-dependent {gamma}-secretase processing regulates multiple ERBB4\/HER4 activities. J Biol Chem. 2005;280(20):19777-19783. 10.1074\/jbc.M412457200.","journal-title":"J Biol Chem"},{"issue":"20","key":"28_CR47_28","first-page":"4890","volume":"53","author":"O Berlin","year":"1993","unstructured":"Berlin O, et al. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Research. 1993;53(20):4890-4895.","journal-title":"Cancer Research"},{"issue":"17","key":"28_CR48_28","doi-asserted-by":"publisher","first-page":"6382","DOI":"10.1158\/1078-0432.CCR-05-0344","volume":"11","author":"P Bali","year":"2005","unstructured":"Bali P, et al. Activity of suberoylanilide hydroxamic acid against human breast cancer cells with amplification of her-2. Clin Cancer Res. 2005;11(17):6382-6389. 10.1158\/1078-0432.CCR-05-0344.","journal-title":"Clin Cancer Res"},{"issue":"39","key":"28_CR49_28","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel CJ, et al. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem. 2001;276(39):36734-36741. %R 10.1074\/jbc.M101287200.","journal-title":"J Biol Chem"},{"issue":"3","key":"28_CR50_28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1158\/0008-5472.CAN-03-0799","volume":"64","author":"N Gurvich","year":"2004","unstructured":"Gurvich N, et al. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res. 2004;64(3):1079-1086. %R 10.1158\/0008-5472.CAN-03-0799.","journal-title":"Cancer Res"},{"issue":"12","key":"28_CR51_28","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1158\/1535-7163.MCT-05-0184","volume":"4","author":"X-N Li","year":"2005","unstructured":"Li X-N, et al. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol Cancer Ther. 2005;4(12):1912-1922. %R 10.1158\/1535-7163.MCT-05-0184.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"28_CR52_28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1378.082","volume":"1091","author":"D Zaskodova","year":"2006","unstructured":"Zaskodova D, et al. Effect of valproic acid, a histone deacetylase inhibitor, on cell death and molecular changes caused by low-dose irradiation. Ann N Y Acad Sci. 2006;1091(1):385-398. %R 10.1196\/annals.1378.082.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"28_CR53_28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1634\/theoncologist.12-8-942","volume":"12","author":"DY Greenblatt","year":"2007","unstructured":"Greenblatt DY, et al. Valproic acid activates Notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist. 2007;12(8):942-951. %R 10.1634\/theoncologist.12-8-942.","journal-title":"Oncologist"},{"issue":"2","key":"28_CR54_28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1677\/joe.1.06970","volume":"191","author":"MG Catalano","year":"2006","unstructured":"Catalano MG, et al. Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells. J Endocrinol. 2006;191(2):465-472. %R 10.1677\/joe.1.06970.","journal-title":"J Endocrinol"},{"issue":"3","key":"28_CR55_28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1200\/JCO.2005.04.063","volume":"23","author":"B Kempf-Bielack","year":"2005","unstructured":"Kempf-Bielack B, et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 2005;23(3):559-568. 10.1200\/JCO.2005.04.063.","journal-title":"J Clin Oncol"},{"issue":"7","key":"28_CR56_28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1080\/02841860500327503","volume":"44","author":"G Bacci","year":"2005","unstructured":"Bacci G, et al. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol. 2005;44(7):748-755.","journal-title":"Acta Oncol"}],"container-title":["Cancer Treatment and Research","Pediatric and Adolescent Osteosarcoma"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4419-0284-9_28.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T03:10:42Z","timestamp":1635045042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4419-0284-9_28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"ISBN":["9781441902832","9781441902849"],"references-count":56,"URL":"https:\/\/doi.org\/10.1007\/978-1-4419-0284-9_28","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4419-0284-9","asserted-by":"object"}]},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}